We are live on ! Find out more
LIP

Liontrust Investment Partners Portfolio holdings

AUM $5.86B
1-Year Est. Return 23.75%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+23.75%
3 Year Est. Return
+74.7%
5 Year Est. Return
10 Year Est. Return
AUM
$7.04B
AUM Growth
-$135M
Cap. Flow
-$106M
Cap. Flow %
-1.51%
Top 10 Hldgs %
30.63%
Holding
236
New
42
Increased
50
Reduced
109
Closed
17

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$121M
2
ADBE icon
Adobe
ADBE
+$106M
3
ILMN icon
Illumina
ILMN
+$66.8M
4
TREX icon
Trex
TREX
+$34.4M
5
ADSK icon
Autodesk
ADSK
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 33.67%
2 Healthcare 17.65%
3 Financials 15.07%
4 Industrials 10.45%
5 Communication Services 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDY icon
226
monday.com
MNDY
$3.7B
-25,000
Closed -$5.65M
MPWR icon
227
Monolithic Power Systems
MPWR
$68.9B
-9,300
Closed -$6.3M
NEM icon
228
Newmont
NEM
$124B
-248,260
Closed -$8.9M
NTES icon
229
NetEase
NTES
$81.9B
-2,000
Closed -$207K
PGNY icon
230
Progyny
PGNY
$2.04B
-45,000
Closed -$1.72M
ROK icon
231
Rockwell Automation
ROK
$49.6B
-45,000
Closed -$13.1M
ROP icon
232
Roper Technologies
ROP
$39.5B
-22,000
Closed -$12.3M
SBUX icon
233
Starbucks
SBUX
$122B
-160,000
Closed -$14.6M
U icon
234
Unity
U
$19.3B
-125,000
Closed -$3.34M
UNH icon
235
UnitedHealth
UNH
$365B
-42,000
Closed -$20.8M

Similar funds

Liontrust Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Liontrust Investment Partners held 236 positions worth $7.04B, down 1.9% from $7.17B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Liontrust Investment Partners's Q2 2024 filing shows 42 new, 50 increased, 109 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 194,894 shares worth $64.2M. The largest sale was Equinix, an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Liontrust Investment Partners's largest Q2 2024 buy was West Pharmaceutical: 194,894 shares worth $64.2M.
  • Liontrust Investment Partners added most to Microsoft in Q2 2024, an estimated $197M increase.
  • Liontrust Investment Partners's biggest Q2 2024 reduction was Equinix, cutting an estimated $121M.
  • Liontrust Investment Partners fully exited UnitedHealth in Q2 2024, selling an estimated $20.8M.
  • Liontrust Investment Partners's ten largest holdings make up 31% of its $7.04B portfolio in Q2 2024.
  • Liontrust Investment Partners opened 42 new positions and closed 17 in Q2 2024.
  • Liontrust Investment Partners's portfolio value fell 1.9% quarter-over-quarter to $7.04B.

Based on Liontrust Investment Partners's 13F filing for Q2 2024, filed 26 Jul 2024.